title: Assessment of high on-treatment platelet reactivity in patients with ischemic heart disease: concordance between the Multiplate and VerifyNow assays.
authors.forename: L
authors.initials: L
authors.lastname: Consuegra-Sánchez
authors.forename: R
authors.initials: R
authors.lastname: López-Palop
authors.forename: P
authors.initials: P
authors.lastname: Cano
authors.forename: P
authors.initials: P
authors.lastname: Carrillo
authors.forename: F
authors.initials: F
authors.lastname: Picó
authors.forename: M
authors.initials: M
authors.lastname: Villegas
authors.forename: J
authors.initials: J
authors.lastname: Sanchis
authors.forename: J C
authors.initials: JC
authors.lastname: Kaski
mesh_terms: D000244:Adenosine Diphosphate; D000368:Aged; D016718:Arachidonic Acid; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D000077144:Clopidogrel; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D011237:Predictive Value of Tests; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D058925:Receptors, Purinergic P2Y12 / Q000097:blood / Q000187:drug effects*; D015203:Reproducibility of Results; D013030:Spain; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: C548576:P2RY12 protein, human; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D016718:Arachidonic Acid; D000244:Adenosine Diphosphate; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin